Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001151 |
Arsenic |
Arsenic affects the expression of HLA-DRB1 mRNA | affects expression | 18414638
|
D001241 |
Aspirin |
HLA-DRB1 gene SNP affects the susceptibility to Aspirin | affects response to substance | 20485159
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of HLA-DRB1 mRNA | decreases expression | 20106945
|
C020711 |
beryllium sulfate |
beryllium sulfate results in increased expression of HLA-DRB1 mRNA | increases expression | 16314022
|
C020711 |
beryllium sulfate |
HLA-DRB1 protein mutant form results in increased susceptibility to beryllium sulfate | increases response to substance | 16272364
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of HLA-DRB1 mRNA | decreases expression | 20106945
|
C051890 |
irinotecan |
irinotecan analog results in increased expression of HLA-DRB1 mRNA | increases expression | 18927307
|
C473384 |
lumiracoxib |
HLA-DRB1 gene SNP affects the susceptibility to lumiracoxib | affects response to substance | 20639878
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of HLA-DRB1 mRNA | increases expression | 12634122
|
D011794 |
Quercetin |
Quercetin results in increased expression of HLA-DRB1 mRNA | increases expression | 16455785
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of HLA-DRB1 mRNA | decreases expression | 20055451
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.08 | 11752688 15322242 14514962 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.02 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.74 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.61 | 16835633 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.48 | 17306315 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
4.41 | 17084956 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.29 | 19183758 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.91 | 16251483 12569548 18414634 16835338 |
MESH:D001172 |
Arthritis, Rheumatoid |
marker/mechanism |
|
| 20453842 19898480 |
MESH:D001249 |
Asthma |
marker/mechanism |
|
| 16792590 |
MESH:D055963 |
Asthma, Aspirin-Induced |
|
Aspirin |
4.84 | 20485159 12372130 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
5.21 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.34 | 12928151 19371607 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 8765331 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
4.62 | 19761891 |
MESH:D001607 |
Berylliosis |
marker/mechanism |
|
| 16272364 17927685 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.21 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.87 | 15746008 |
MESH:D001932 |
Brain Neoplasms |
|
Aspirin |
4.58 | 15481559 |
MESH:D001943 |
Breast Neoplasms |
|
Aspirin |
2.01 | 15161893 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.01 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
2.01 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.01 | 20435547 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
5.81 | 16962696 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.68 | 15504454 17687452 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
3.41 | 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
3.41 | 19519916 12508355 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
5.17 | 17234771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
4.86 | 18922899 17687452 15504454 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.86 | 20419170 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.24 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
7.09 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
7.09 | 16120746 18850075 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.56 | 17938729 15738583 19152805 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.46 | 18022660 16973168 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.41 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
7.41 | 2727394 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.04 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 8697196 15340226 15668235 12621046 16354765 |
MESH:D003110 |
Colonic Neoplasms |
|
Aspirin |
6.21 | 12411196 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
6.21 | 17287894 17725105 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
6.21 | 19440933 11134977 17191121 17148506 16640504 19056647 15741050 |
MESH:D015179 |
Colorectal Neoplasms |
|
Aspirin |
3.73 | 17047198 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
3.73 | 17159606 15273666 18259882 17454858 16391804 16303861 18509181 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
3.73 | 18095365 18852136 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
3.87 | 19496084 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
MESH:D004342 |
Drug Hypersensitivity |
marker/mechanism |
|
| 20485159 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
lumiracoxib |
4.78 | 20639878 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.78 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.89 | 11462148 |
MESH:D004487 |
Edema |
|
Aspirin |
7.63 | 17259670 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.63 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 10568697 9294722 |
MESH:D016603 |
Eosinophilia-Myalgia Syndrome |
marker/mechanism |
|
| 19790128 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.04 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.03 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
16.08 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
16.08 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
16.08 | 20067830 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.82 | 6392382 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.46 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Aspirin |
7.96 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
7.96 | 19804834 |
MESH:D005910 |
Glioma |
|
Quercetin |
3.11 | 17643826 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
MESH:D006261 |
Headache |
|
Aspirin |
5.22 | 15240983 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.72 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.72 | 10048152 11294989 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.66 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.11 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 8697196 16959395 15340226 18606429 16354765 |
MESH:D012001 |
Hyperacusis |
|
Aspirin |
6.03 | 15240983 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
4.19 | 11834736 18262572 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.62 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
12.86 | 16076760 11953799 9931084 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
12.86 | 10903974 |
MESH:D006973 |
Hypertension |
|
Quercetin |
12.86 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
12.86 | 18850075 18670907 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.82 | 16093927 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.93 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
4.77 | 16624496 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
MESH:D007627 |
Keloid |
|
Quercetin |
5.17 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.71 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.23 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.43 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
6.43 | 16962696 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.88 | 12371664 |
MESH:D007938 |
Leukemia |
|
Quercetin |
3.23 | 17468513 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.66 | 17339181 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
2.49 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.49 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.57 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
11.21 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
11.21 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
11.21 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.21 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
6.26 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.26 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
5.00 | 19168569 17306315 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
5.00 | 18816296 20869020 20464547 17053015 18569708 6695378 20135361 18520028 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
5.00 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
5.00 | 11884234 19555203 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.05 | 16801185 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
6.13 | 17671175 |
MESH:D008881 |
Migraine Disorders |
|
Aspirin |
4.18 | 15240983 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.32 | 16381670 |
MESH:D052016 |
Mucositis |
|
irinotecan |
5.25 | 17159606 |
MESH:D009103 |
Multiple Sclerosis |
marker/mechanism |
|
| |
MESH:D009203 |
Myocardial Infarction |
|
Aspirin |
6.46 | 12692751 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
6.46 | 19595682 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
9.47 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.47 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
3.92 | 19207477 |
MESH:D009325 |
Nausea |
|
Aspirin |
5.48 | 15240983 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.23 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.39 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
5.39 | 15185748 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.71 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
marker/mechanism |
|
| 11095018 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.44 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.41 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
3.56 | 16620997 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.56 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.97 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
11.31 | 17056641 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
11.31 | 17929310 |
MESH:D010003 |
Osteoarthritis |
|
Aspirin |
9.02 | 7009135 |
MESH:D010003 |
Osteoarthritis |
|
lumiracoxib |
9.02 | 20639878 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
4.40 | 19495926 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
5.30 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
5.30 | 19005980 |
MESH:D010146 |
Pain |
|
Aspirin |
8.49 | 6995502 6363464 |
MESH:D010146 |
Pain |
|
lumiracoxib |
8.49 | 20639878 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
2.90 | 16965848 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
MESH:D010438 |
Peptic Ulcer Hemorrhage |
|
Aspirin |
5.78 | 11156591 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.38 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.23 | 15371236 6392382 16905509 |
MESH:D020795 |
Photophobia |
|
Aspirin |
6.03 | 15240983 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.62 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
9.62 | 19056647 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.43 | 11222880 11118676 11399792 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.60 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.60 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
2.60 | 14715546 17292933 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
4.19 | 21343184 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.28 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
MESH:D012220 |
Rhinitis |
|
Aspirin |
4.53 | 12372130 |
MESH:D012507 |
Sarcoidosis |
marker/mechanism |
|
| 14508706 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
5.81 | 16862918 |
MESH:D012559 |
Schizophrenia |
marker/mechanism |
|
| 16223876 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Aspirin |
5.48 | 12269725 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.78 | 16759981 19834688 16702368 18709164 17548696 16353154 6392382 17938729 15952646 17050553 17453740 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
9.87 | 17050553 19538983 16251483 15504454 17029826 17976673 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.87 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.87 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.59 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
2.59 | 15723263 |
MESH:D020521 |
Stroke |
|
Aspirin |
4.51 | 16403987 |
MESH:D013927 |
Thrombosis |
|
Aspirin |
4.67 | 17672075 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
8.76 | 17306315 17976673 15987713 18640142 11144890 19429237 19322015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.76 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
8.76 | 16720314 |
MESH:D014581 |
Urticaria |
marker/mechanism |
|
| 20485159 |
MESH:D014581 |
Urticaria |
|
Aspirin |
4.62 | 10982225 20485159 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.25 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.97 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.71 | 17120751 |